Cargando…
Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges
The population of patients with hepatocellular carcinoma (HCC) overlaps to a high degree with those for chronic kidney disease (CKD) and end-stage renal disease (ESRD). The degrees of renal dysfunction vary, from the various stages of CKD to dialysis-dependent ESRD, which often affects the prognosis...
Autores principales: | Yeh, Hsuan, Chiang, Chung-Cheng, Yen, Tzung-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311541/ https://www.ncbi.nlm.nih.gov/pubmed/34326614 http://dx.doi.org/10.3748/wjg.v27.i26.4104 |
Ejemplares similares
-
Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma
por: Chiang, Chun-Cheng, et al.
Publicado: (2023) -
Outcomes of Geriatric Patients with Hepatocellular Carcinoma
por: Lee, Chern-Horng, et al.
Publicado: (2022) -
Pathophysiology, prognosis and treatment of tardive
dyskinesia
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2022) -
Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma
por: LE, PUO-HSIEN, et al.
Publicado: (2014) -
Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response
por: Dash, Srikanta, et al.
Publicado: (2016)